|
1
|
Travers JG, Kamal FA, Robbins J, Yutzey KE
and Blaxall BC: Cardiac fibrosis: The fibroblast awakens. Circ Res.
118:1021–1040. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Broughton KM, Wang BJ, Firouzi F,
Khalafalla F, Dimmeler S, Fernandez-Aviles F and Sussman MA:
Mechanisms of cardiac repair and regeneration. Circ Res.
122:1151–1163. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Segura AM, Frazier OH and Buja LM:
Fibrosis and heart failure. Heart Fail Rev. 19:173–185.
2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fan D, Takawale A, Lee J and Kassiri Z:
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling
in heart disease. Fibrogenesis Tissue Repair. 5(15)2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Alex L and Frangogiannis NG: The cellular
origin of activated fibroblasts in the infarcted and remodeling
myocardium. Circ Res. 122:540–542. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang YS, Li SH, Guo J, Mihic A, Wu J, Sun
L, Davis K, Weisel RD and Li RK: Role of miR-145 in cardiac
myofibroblast differentiation. J Mol Cell Cardiol. 66:94–105.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ma ZG, Yuan YP, Wu HM, Zhang X and Tang
QZ: Cardiac fibrosis: New insights into the pathogenesis. Int J
Biol Sci. 14:1645–1657. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Penas FN, Carta D, Dmytrenko G, Mirkin GA,
Modenutti CP, Cevey ÁC, Rada MJ, Ferlin MG, Sales ME and Goren NB:
Treatment with a new peroxisome proliferator-activated receptor
gamma agonist, pyridinecarboxylic acid derivative, increases
angiogenesis and reduces inflammatory mediators in the heart of
Trypanosoma cruzi-infected mice. Front Immunol.
8(1738)2017.
|
|
9
|
Periasamy S, Chen SY and Liu MY: The study
of ISO induced heart failure rat model, Exp Mol Pathol.
2010;88:299-304. Exp Mol Pathol 90: 84, 2011.
|
|
10
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM
and Zhang GZ: Biological functions of microRNAs: A review. J
Physiol Biochem. 67:129–139. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu X, Xu Y, Deng Y and Li H: MicroRNA-223
regulates cardiac fibrosis after myocardial infarction by targeting
RASA1. Cell Physiol Biochem. 46:1439–1454. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang D, Cui Y, Li B, Luo X, Li B and Tang
Y: miR-155 regulates high glucose-induced cardiac fibrosis via the
TGF-β signaling pathway. Mol Biosyst. 13:215–224. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lee HM, Kim TS and Jo EK: MiR-146 and
miR-125 in the regulation of innate immunity and inflammation. BMB
Rep. 49:311–318. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Morishita Y, Imai T, Yoshizawa H, Watanabe
M, Ishibashi K, Muto S and Nagata D: Delivery of microRNA-146a with
polyethylenimine nanoparticles inhibits renal fibrosis in vivo. Int
J Nanomedicine. 10:3475–3488. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yuan BY, Chen YH, Wu ZF, Zhuang Y, Chen
GW, Zhang L, Zhang HG, Cheng JC, Lin Q and Zeng ZC:
MicroRNA-146a-5p Attenuates fibrosis-related molecules in
irradiated and TGF-beta1-treated human hepatic stellate cells by
regulating PTPRA-SRC signaling. Radiat Res. 192:621–629.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pan J, Alimujiang M, Chen Q, Shi H and Luo
X: Exosomes derived from miR-146a-modified adipose-derived stem
cells attenuate acute myocardial infarction-induced myocardial
damage via downregulation of early growth response factor 1. J Cell
Biochem. 120:4433–4443. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shi H, Xu J, Zhao R, Wu H, Gu L and Chen
Y: FGF2 regulates proliferation, migration, and invasion of ECA109
cells through PI3K/Akt signalling pathway in vitro. Cell Biol Int.
40:524–533. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wu J, Ye J, Zhu J, Xiao Z, He C, Shi H,
Wang Y, Lin C, Zhang H, Zhao Y, et al: Heparin-based coacervate of
FGF2 improves dermal regeneration by asserting a synergistic role
with cell proliferation and endogenous facilitated VEGF for
cutaneous wound healing. Biomacromolecules. 17:2168–2177.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Schreier T, Degen E and Baschong W:
Fibroblast migration and proliferation during in vitro wound
healing. A quantitative comparison between various growth factors
and a low molecular weight blood dialysate used in the clinic to
normalize impaired wound healing. Res Exp Med (Berl). 195–205.
1993.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lu J, Wang QY, Zhou Y, Lu XC, Liu YH, Wu
Y, Guo Q, Ma YT and Tang YQ: Astragaloside Ⅳ against cardiac
fibrosis by inhibiting TRPM7 channel. Phytomedicine. 30:10–17.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
No authors listed. Myocardial infarction
redefined - a consensus document of The Joint European Society of
Cardiology/American College of Cardiology Committee for the
redefinition of myocardial infarction. Eur Heart J. 21:1502–1513.
2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yuan J, Chen H, Ge D, Xu Y, Xu H, Yang Y,
Gu M, Zhou Y, Zhu J, Ge T, et al: Mir-21 promotes cardiac fibrosis
after myocardial infarction via targeting Smad7. Cell Physiol
Biochem. 42:2207–2219. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wei Y, Yan X, Yan L, Hu F, Ma W, Wang Y,
Lu S, Zeng Q and Wang Z: Inhibition of microRNA 155 ameliorates
cardiac fibrosis in the process of angiotensin II induced cardiac
remodeling. Mol Med Rep. 16:7287–7296. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang J, Lang Y, Guo L, Pei Y, Hao S,
Liang Z, Su G, Shu L, Liu H, Huang C, et al: MicroRNA-323a-3p
promotes pressure overload-induced cardiac fibrosis by targeting
TIMP3. Cell Physiol Biochem. 50:2176–2187. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zou Y, Cai Y, Lu D, Zhou Y, Yao Q and
Zhang S: MicroRNA-146a-5p attenuates liver fibrosis by suppressing
profibrogenic effects of TGFβ1 and lipopolysaccharide. Cell Signal.
39:1–8. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Huang W, Tian SS, Hang PZ, Sun C, Guo J
and Du ZM: Combination of microRNA-21 and microRNA-146a attenuates
cardiac dysfunction and apoptosis during acute myocardial
infarction in mice. Mol Ther Nucleic Acids. 5(e296)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Werner S and Grose R: Regulation of wound
healing by growth factors and cytokines. Physiol Rev. 83:835–870.
2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shi K, Qiu X, Zheng W, Yan D and Peng W:
miR-203 regulates keloid fibroblast proliferation, invasion, and
extracellular matrix expression by targeting EGR1 and FGF2. Biomed
Pharmacother. 108:1282–1288. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
House SL, House BE, Glascock B, Kimball T,
Nusayr E, Schultz JE and Doetschman T: fibroblast growth factor 2
mediates isoproterenol-induced cardiac hypertrophy through
activation of the extracellular regulated kinase. Mol Cell
Pharmacol. 2:143–154. 2010.PubMed/NCBI View Article : Google Scholar
|
